Tabrecta® (capmatinib)
for Lung Cancer

Tabrecta (capmatinib) is a kinase inhibitor used to treat adults with metastatic non-small cell lung cancer (NSCLC) that cannot be removed by surgery and has an abnormal MET gene. It works by slowing or stopping the growth of cancer cells.

Heart